Published in Tissue Antigens on June 01, 2014
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Divide, Conquer, and Sense: CD8(+)CD28(-) T Cells in Perspective. Front Immunol (2017) 0.77
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol (2006) 5.54
Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol (2013) 4.33
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med (2003) 3.61
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant (2012) 2.46
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation (2009) 2.28
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16
C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation (2008) 2.04
The cytoskeleton, cellular motility and the reductionist agenda. Nature (2003) 2.02
Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res (1982) 1.79
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation. Transplantation (2012) 1.49
Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol (1994) 1.45
Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A (2007) 1.39
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol (2008) 1.33
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol (2008) 1.31
Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant (2014) 1.29
Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol (2006) 1.25
Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant (2007) 1.18
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol (2004) 1.16
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol (2009) 1.09
RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol (2007) 1.08
Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol (2002) 1.07
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int (2005) 1.07
HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration. Sci Signal (2010) 1.06
Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant (2006) 1.05
Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol (2012) 1.05
Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant (2005) 1.03
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs. J Immunol (2013) 1.02
RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy. J Am Soc Nephrol (2004) 1.02
Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circ Res (2003) 1.01
Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. Circulation (2013) 1.00
Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol (1999) 0.99
Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol (2004) 0.99
Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. Am J Transplant (2013) 0.98
Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant (2012) 0.98
Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant (2012) 0.97
The nucleoporin Nup153 maintains nuclear envelope architecture and is required for cell migration in tumor cells. FEBS Lett (2010) 0.96
Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol (1997) 0.95
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant (2013) 0.95
Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant (2009) 0.94
HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol (2005) 0.93
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
Characterization of the endothelial cell cytoskeleton following HLA class I ligation. PLoS One (2012) 0.91
Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation (2008) 0.89
HLA class I signal transduction is dependent on Rho GTPase and ROK. Biochem Biophys Res Commun (2004) 0.89
Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection. Transplantation (2013) 0.89
Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation (2011) 0.89
A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody. Circulation (2011) 0.89
Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner. Hum Immunol (2011) 0.88
Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus. Am J Transplant (2014) 0.88
rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant (2011) 0.88
Allograft arteriosclerosis and immune-driven angiogenesis. Circulation (2003) 0.87
Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection. Am J Pathol (2011) 0.86
Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol (1998) 0.86
Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability. Int J Biochem Cell Biol (2009) 0.86
Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack. Biochem Biophys Res Commun (2009) 0.86
The fate of renal allografts hinges on responses of the microvascular endothelium. Exp Mol Pathol (2012) 0.85
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. J Heart Lung Transplant (2007) 0.85
Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg (2006) 0.85
Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats. Am J Hypertens (2007) 0.85
Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation. J Heart Lung Transplant (2013) 0.85
HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cells. Am J Physiol Cell Physiol (2012) 0.84
Antibodies against nucleolin in recipients of organ transplants. Transplantation (2011) 0.84
Acute cellular rejection: impact of donor-specific antibodies and C4d. Transplantation (2014) 0.83
Binding of anti-HLA class I antibodies to airway epithelial cells induces activation and growth factor production and indirectly upregulates lung fibroblast proliferation. J Heart Lung Transplant (2001) 0.83
A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model. J Heart Lung Transplant (2001) 0.82
Sirolimus (rapamycin) monotherapy prevents graft vascular disease in nonhuman primate recipients of orthotopic aortic allografts. Circulation (2003) 0.81
Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. J Heart Lung Transplant (2005) 0.81
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. Transplantation (2014) 0.81
The link between major histocompatibility complex antibodies and cell proliferation. Transplant Rev (Orlando) (2011) 0.79
Antibody-mediated rejection: an evolving entity in heart transplantation. J Transplant (2012) 0.79
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels. J Heart Lung Transplant (2004) 0.78
Antibody-Mediated Lung Transplant Rejection. Curr Respir Care Rep (2012) 0.78
Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies. Transplantation (2010) 0.78
HLA high-resolution typing for sensitized patients: a solution in search of a problem? Am J Transplant (2015) 1.58
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
Effect of antibodies on endothelium. Am J Transplant (2009) 1.23
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol (1993) 1.08
Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant (2006) 1.05
Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J Immunol (1993) 1.03
Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun (2008) 1.01
Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol (1999) 0.99
Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant (2012) 0.98
Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol (1997) 0.95
Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J Immunol (1997) 0.94
KIR2DL5 alleles mark certain combination of activating KIR genes. Genes Immun (2008) 0.93
Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortium. Am J Transplant (2013) 0.91
Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus. Am J Transplant (2014) 0.88
Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol (1998) 0.86
Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation. Transplant Proc (2001) 0.85
Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. Am J Transplant (2013) 0.84
HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity. J Immunol (1999) 0.84
A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens (2009) 0.84
Immunologic monitoring in lung allograft recipients. Transplantation (1996) 0.83
14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation. Tissue Antigens (2007) 0.82
Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc (1995) 0.81
Indirect recognition of donor MHC Class II antigens in human transplantation. Clin Immunol Immunopathol (1996) 0.80
Suppression of the indirect pathway of T cell reactivity by high doses of allopeptide. Autoimmunity (1995) 0.79
Mapping of dominant HLA-DR determinants recognized via the indirect pathway. Transplant Proc (1997) 0.78
Precision diagnostics in transplantation: from bench to bedside. Am J Transplant (2012) 0.78
Differential expression of insulin-dependent diabetes mellitus-associated HLA-DQA1 alleles in vivo. Eur J Immunol (1997) 0.78
Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules. J Exp Med (1993) 0.78
Role of indirect allorecognition in chronic rejection of human allografts. Transplant Proc (1996) 0.77
Indirect T-cell recognition in human allograft rejection. Transplant Proc (1997) 0.76
Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells. Immunol Res (1993) 0.75
RFLP characterization of the upstream regulatory region of the HLA-DQA1 gene. Tissue Antigens (1994) 0.75
Polymorphism in the 5' terminal region of the mRNA of HLA-DQA1 gene: identification of four groups of transcripts and their association with polymorphism in the alpha 1 domain. Hum Immunol (1997) 0.75
Influence of HLA matching on kidney allograft survival. Transplant Proc (1996) 0.75
Influence of HLA matching on kidney allograft survival: UNOS allocation system greatly improves the outcome. Transplant Proc (1995) 0.75
Anti-HLA antibodies transduce proliferative signals in endothelial cells and smooth muscle cells. Transplant Proc (1999) 0.75